• Skip to main content
  • Skip to header right navigation
  • Skip to after header navigation
  • Skip to site footer
NeuronUP

NeuronUP

NeuronUP. Web platform of cognitive rehabilitation

Login
Free Trial
  • Product
        • Cognitive intervention
        • Activities
        • Sessions
        • Home sessions
        • Programs
        • User Management
        • Analysis and monitoring
  • Use cases
        • Acquired brain damage
        • Normal aging
        • Neurodegenerative diseases
        • Neurodevelopmental disorders
        • Intellectual disability
        • Mental illness
  • Customers
  • Prices
  • More
        • Blog
        • About us
        • Neurorehabilitation
        • Research
        • Areas of Intervention
        • Theoretical framework
        • Growing as a professional
  • Contact
  • Service and support
        • Help Center
        • FAQs
  • Free Trial
  • Login
Login
Free Trial
  • Contact
  • Service and support
    • Help Center
    • FAQs
    • English
    • Spanish
    • Portuguese
    • French


Alzheimer’s Disease

Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common type of dementia. In the United States, about 5,8 million people suffer from this disease.

You are here: Home / Neurorehabilitation / Neurodegenerative Diseases / Alzheimer’s Disease

This type of dementia usually starts slowly, first affecting the parts of the brain responsible for memory, thinking, and language. Over time, these symptoms worsen up to the point of patients failing to recognize closest relatives and experiencing problems in basic activities of daily living such as dressing or grooming. In addition to the distinctive memory problems, Alzheimer patients develop other symptoms such as changes in reasoning skills, aphasia, apraxia, deficits in visuospatial abilities, and changes in mood and personality.

The neuropathological hallmarks of Alzheimer’s disease are senile plaques and neurofibrillary tangles in the cerebral cortex, as well as neuronal and synaptic loss.

The criteria for the clinical diagnosis of probable Alzheimer’s disease include the following:

  • Dementia established by clinical examination and documented by neuropsychological tests
  • Deficits in two or more areas of cognition
  • Progressive worsening of memory and other cognitive functions
  • No disturbance of consciousness
  • Onset between ages 40 and 90
  • Absence of systemic disorders or other brain diseases that in and of themselves could account for the progressive deficits in memory and cognition

Prognostic factors in Alzheimer’s disease are:

  • Visuospatial deficits
  • Extrapyramidal signs
  • Psychosis, depression
  • Initial severity of dementia, functional disability
  • Malnutrition, diabetes mellitus, lack of physical exercise, and cardiovascular disease

Finally, regarding treatment, there is currently no drug that can reverse the symptoms of this disease. However, there are medications called acetylcholinesterase inhibitors which delay the progression of Alzheimer’s disease, especially in early to moderate stages.

References: McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan E. M. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34(7), 939-44. doi: 10.1212/WNL.34.7.939 See more at: http://www.neurology.org/content/34/7/939.full.pdf+html

10 cognitive rehabilitation and stimulation worksheets

Get printable exercises to work on different areas of intervention with adults and children. Developed by and for professionals. Hope you like them!

NeuronUP logotype

Cognitive stimulation platform for professionals

Contact

Service and support

FAQs

Help center NeuronUP

NeuronUP Changelog

Plataform

Professional Solutions

Pricing

NeuronUP2GO Packs

Information request

Resources

NeuronUP University Program

News

Neurorehabilitation

Neurodegenerative Diseases

Neurodevelopmental Disorders

Acquired Brain Injury

Intellectual Disability

Mental Illness

Normal Aging

NeuronUP Academy

Areas of Intervention

Cognitive Functions

Activities of Daily Living (ADLs)

Social Skills

Research

Research Publications

Research Tools

Theoretical Framework

mail

Get the latest news directly to your inbox

Subscribe

© 2023 NeuronUP

  • Twitter
  • Instagram
  • LinkedIn
  • YouTube

Privacy Policy

Legal Disclaimer

Cookies

Terms and Conditions

English

Spanish

Portuguese (Brazil)

French

NeuronUP
Manage cookie consent
We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The storage or technical access is necessary for the legitimate purpose of storing preferences not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Technical storage or access that is used for anonymous statistical purposes only. Without a request, voluntary compliance by your Internet Service Provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
The storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or multiple websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}